Alopecia

Oral JAK3 Inhibitor Granted Breakthrough Tx Designation for Alopecia Areata

By September 05, 2018

PF-06651600 is an investigational oral Janus kinase 3 (JAK3) inhibitor that is being evaluated in a Phase 2 study which will assess the treatment based on changes from baseline in Severity of Alopecia Tool (SALT) score.

Adverse Effect of Osteoporosis Drug May Help Treat Hair Loss

By May 11, 2018

Researchers found that a non-immunosuppressant drug originally designed to treat osteoporosis (WAY-316606) targeted the same mechanism by antagonizing SFRP1, and after treating hair follicles with WAY-316606 for 6 days, the authors found enhanced human hair growth.

Endocrine Therapy-Induced Alopecia Seen in Breast Cancer

April 12, 2018

"Endocrine therapies are associated with a pattern alopecia similar to androgenetic-type, consistent with the mechanism of action of causal agents," the authors write.

Potential First-in-Class Treatment Fast-Tracked for Alopecia Areata

By January 12, 2018

Currently, there are no FDA approved treatments for alopecia areata.

PRP Injections Promising for Female Pattern Hair Loss

May 18, 2017

Significant improvement in hair volume and quality in PRP-injected sites, plus patient satisfaction